Back to the future--radiotherapy in high grade gliomas.

por Brada, M.
Publicado 1989

NICE verdict on Temozolomide: where next?

por Brada, M
Publicado 2002

Spinal seeding in cranial germinoma.

por Brada, M., Rajan, B.
Publicado 1990

Changing patterns of relapse in Hodgkin's disease.

por Duchesne, G., Crow, J., Ashley, S., Brada, M., Horwich, A.
Publicado 1989

Non-Hodgkin's lymphoma presenting with extradural spinal cord compression: functional outcome and survival.

por Eeles, R. A., O'Brien, P., Horwich, A., Brada, M.
Publicado 1991

Peripheral blood involvement in non-Hodgkin's lymphoma detected by clonal gene rearrangement as a biological prognostic marker.

por Hiorns, L. R., Nicholls, J., Sloane, J. P., Horwich, A., Ashley, S., Brada, M.
Publicado 1994

Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement.

por Brada, M., Mizutani, S., Molgaard, H., Sloane, J. P., Treleaven, J., Horwich, A., Peckham, M. J.
Publicado 1987

Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.

por Brada, M., Thomas, G., Elyan, S., James, N., Hines, F., Ashley, S., Marsh, H., Bell, B. A., Stenning, S.
Publicado 1995

Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

por Brada, M, Judson, I, Beale, P, Moore, S, Reidenberg, P, Statkevich, P, Dugan, M, Batra, V, Cutler, D
Publicado 1999

ChlVPP combination chemotherapy for Hodgkin's disease: long-term results.

por Selby, P., Patel, P., Milan, S., Meldrum, M., Mansi, J., Mbidde, E., Brada, M., Perren, T., Forgeson, G., Gore, M.
Publicado 1990

Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy

por Murphy, P S, Viviers, L, Abson, C, Rowland, I J, Brada, M, Leach, M O, Dzik-Jurasz, A S K
Publicado 2004

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

por Yung, W K A, Albright, R E, Olson, J, Fredericks, R, Fink, K, Prados, M D, Brada, M, Spence, A, Hohl, R J, Shapiro, W, Glantz, M, Greenberg, H, Selker, R G, Vick, N A, Rampling, R, Friedman, H, Phillips, P, Bruner, J, Yue, N, Osoba, D, Zaknoen, S, Levin, V A
Publicado 2000

Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome

por Favero, F., McGranahan, N., Salm, M., Birkbak, N. J., Sanborn, J. Z., Benz, S. C., Becq, J., Peden, J. F., Kingsbury, Z., Grocok, R. J., Humphray, S., Bentley, D., Spencer-Dene, B., Gutteridge, A., Brada, M., Roger, S., Dietrich, P.-Y., Forshew, T., Gerlinger, M., Rowan, A., Stamp, G., Eklund, A. C., Szallasi, Z., Swanton, C.
Publicado 2015

Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer

por Basu, B, Krebs, M G, Sundar, R, Wilson, R H, Spicer, J, Jones, R, Brada, M, Talbot, D C, Steele, N, Ingles Garces, A H, Brugger, W, Harrington, E A, Evans, J, Hall, E, Tovey, H, de Oliveira, F M, Carreira, S, Swales, K, Ruddle, R, Raynaud, F I, Purchase, B, Dawes, J C, Parmar, M, Turner, A J, Tunariu, N, Banerjee, S, de Bono, J S, Banerji, U
Publicado 2018